KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Accumulated Expenses (2016 - 2026)

CareDx's Accumulated Expenses history spans 14 years, with the latest figure at $49.5 million for Q1 2026.

  • On a quarterly basis, Accumulated Expenses rose 15.5% to $49.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $49.5 million, a 15.5% increase, with the full-year FY2025 number at $38.1 million, down 12.1% from a year prior.
  • Accumulated Expenses hit $49.5 million in Q1 2026 for CareDx, up from $38.1 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for CDNA hit a ceiling of $49.5 million in Q1 2026 and a floor of $11.4 million in Q1 2022.
  • Historically, Accumulated Expenses has averaged $31.8 million across 5 years, with a median of $38.1 million in 2025.
  • Biggest five-year swings in Accumulated Expenses: plummeted 69.23% in 2023 and later surged 278.0% in 2024.
  • Tracing CDNA's Accumulated Expenses over 5 years: stood at $16.9 million in 2022, then increased by 16.57% to $19.7 million in 2023, then skyrocketed by 120.03% to $43.4 million in 2024, then dropped by 12.1% to $38.1 million in 2025, then skyrocketed by 30.01% to $49.5 million in 2026.
  • Business Quant data shows Accumulated Expenses for CDNA at $49.5 million in Q1 2026, $38.1 million in Q4 2025, and $23.2 million in Q3 2025.